This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2024
AUA 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Carcinoma
Testicular and Penile Cancer
Press Releases
Sexual Dysfunction
Endourology and Stone Disease
Lowery Urinary Tract Conditions
AUA 2024 Prostate Cancer
Viewing 1-20 of 65 articles
AUA 2024: EvoPAR-Prostate01: Phase III, Double-Blind, Placebo-Controlled, 2-Cohort, Randomized Study of Saruparib (AZD5305) in Combination with New Hormonal Agents in Patients with mCSPC +/- HRR Mutations
AUA 2024: Evaluating AI Assistance in Prostate bpMRI Interpretation: A Multi-Reader Study
AUA 2024: Panel Discussion: Tricks and Tips of Penile Prosthesis Surgery
AUA 2024: Crossfire: Controversies in Urology: Detrusor Underactivity in Men in Retention: To TURP or Not to TURP?
AUA 2024: Crossfire: Controversies in Urology: Testosterone Therapy May Be Reasonably Offered to Men on Active Surveillance – Pro/Con
AUA 2024: Can Genitourinary Cancer Survivors Understand Quality of Life (QoL) Questionnaires? Assessing the Readability of Commonly Used Urologic Oncology QoL Instruments
AUA 2024: Epidemiology Applied to Focal Therapy in Prostate Cancer: Where do we Stand?
AUA 2024: Third Interim Analysis of the DARolutamide ObservationaL (DAROL) Study in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
AUA 2024: Phase II Study of Neoadjuvant Lu-177-PSMA-617 in Patients with High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy (PRELUDE Trial)
AUA 2024: Updates on Metastasis Directed Therapy
AUA 2024: Darolutamide Real-World Doublet and Triplet Utilization in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): US Community Urology Setting
AUA 2024: Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence
AUA 2024: Evaluation of Response to 177Lu-PSMA-617 by Site Specific Disease in Metastatic Castrate-Resistant Prostate Cancer
AUA 2024: Major Complications and Adverse Events of SpaceOAR Hydrogel: An Analysis of the Manufacturer and User Facility Device Experience Database
AUA 2024: Review of SpaceOAR Complications in The MAUDE Database with Focus on Rectal Wall Infiltration
AUA 2024: Temporal and Regional Patterns of Prostate Cancer Positron Emission Tomography Imaging Among Commercial Insurance Beneficiaries in the United States
AUA 2024: PSMA-PET Guided Metastasis Directed Therapy for Oligometastatic Prostate Cancer
AUA 2024: Genetic Testing in Prostate Cancer: The Role of the Urologists
AUA 2024: Prostate Cancer: Dissemination and Availability of Minimally Invasive Treatments to Underserved Populations
AUA 2024: Prostate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients with Biochemical Recurrent Prostate Cancer: A Retrospective Cohort Study
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free